AWS technologies enhance the speed, scale, and analytical power of BC Platforms’ trusted research environments, enabling global collaboration on multi-modal real-world data while supporting European Health Data Space (EHDS) readiness across Europe ZURICH — BC Platforms, a global leader in healthcare data, technology, and analytics, announced today that it has signed a Strategic Collaboration Agreement with […]
ERAPs (ERAP1 and ERAP2) are emerging therapeutic targets associated with multiple autoimmune diseases. Genomics will assemble the largest available genetic resource to evaluate how ERAP variants influence an individual’s risk of developing multiple autoimmune diseases. Insights will be used to strengthen Greywolf Therapeutics’ autoimmune disease pipeline. Oxford, England — Genomics, a science-led techbio company using large-scale […]
Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery Integrated solutions: Seamless integration of EDGE-developed quantitative assays with scalable hardware and AI-driven analytics from ZEISS to redefine bioimaging in biopharma Strategic focus: Enabling automation and enhancing decision-making through quantitative imaging, establishing an AI-native data foundation accelerating GenAI adoption Customer impact: Standardized […]
We are happy to announce OmicsBox Web, a new browser-based companion to BioBam’s OmicsBox platform. OmicsBox Web is available at https://omicsbox.biobam.com and uses the same OmicsBox account credentials, so analysis jobs launched via OmicsBox, input data and results as well as account settings are now reachable from any device with a web browser. OmicsBox Web is designed to complement the […]
SAN FRANCISCO BAY AREA, Calif. — 10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed round led by Initialized Capital. The oversubscribed round includes investments from Y Combinator, Civilization Ventures, Founder Factor, and a group of strategic angel investors. Starting with drug […]
Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making RESEARCH TRIANGLE PARK, N.C.–Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a funded research collaboration […]
Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve as a foundation for lab workflows, enabling standardized nucleic acid extraction for clinical and translational research Introduction of the QIAGEN Discovery Platform, an AI-grounding solution to power downstream AI applications and support drug […]
Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research New pangenome representation, default personalization, and machine learning features boost analytical capabilities across applications SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most […]
SAN DIEGO and NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, will adopt the AI-powered SOPHiA DDM™ Platform to advance cancer research and enhance genomic testing capabilities. Mount Sinai, a National […]
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster. Key takeaways AI-powered application assisting scientists with drug design paired with lab testing creates a loop where each experiment improves the next. Scientists can access leading AI models, view benchmarks, and use an AI agent to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
